Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.40), $0.06 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $79.46 million versus the consensus estimate of $94.07 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.